Evidence map›Paper›PMID 37059467›Full record

ArticleRNA (New York, N.Y.)2023

Formamide significantly enhances the efficiency of chemical adenylation of RNA sequencing ligation adaptors.

Samuel R Hildebrand, Adam K Hedger, Ken Yamada, Jonathan K Watts, Anastasia Khvorova

Abstract read
In one paragraph

Article in RNA (New York, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Samuel R HildebrandRNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts 01655, USA.ORCID 0000-0002-6633-3495
Adam K HedgerRNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts 01655, USA.ORCID 0000-0003-1529-2598
Ken YamadaRNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts 01655, USA.
Jonathan K WattsRNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts 01655, USA.ORCID 0000-0001-5706-1734
Anastasia KhvorovaRNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts 01655, USA anastasia.khvorova@umassmed.edu.ORCID 0000-0001-6928-8071

Funding

Next-generation antisense therapeutics for ALS and frontotemporal dementiaR01NS111990 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Robert H Brown, Jonathan K Watts · 2019 to 2026
$5.2M
Chemical engineering of therapeutic RNAs for extrahepatic deliveryR35GM131839 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ANASTASIA KHVOROVA · 2019 to 2026
$3.1M
Mid-Scale RNA Synthesis, Purification and Quality Control SystemS10OD020012 · OD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KHVOROVA, ANASTASIA · 2015 to 2015
$563k
The Impact of Nucleotide Modification Patterns on Therapeutic Small Interfering RNA Activity in the Central Nervous SystemF31NS122493 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI HILDEBRAND, SAMUEL · 2022 to 2024
$91k
NIGMS NIH HHS R35 GM131839NIH HHS S10 OD020012NINDS NIH HHS F31 NS122493NINDS NIH HHS R01 NS111990
6 · The paper itself

Abstract

Preadenylated single-stranded DNA ligation adaptors are essential reagents in many next generation RNA sequencing library preparation protocols. These oligonucleotides can be adenylated enzymatically or chemically. Enzymatic adenylation reactions have high yield but are not amendable to scale up. In chemical adenylation, adenosine 5'-phosphorimidazolide (ImpA) reacts with 5' phosphorylated DNA. It is easily scalable but gives poor yields, requiring labor-intensive cleanup steps. Here, we describe an improved chemical adenylation method using 95% formamide as the solvent, which results in the adenylation of oligonucleotides with >90% yield. In standard conditions, with water as the solvent, hydrolysis of the starting material to adenosine monophosphate limits the yields. To our surprise, we find that rather than increasing adenylation yields by decreasing the rate of ImpA hydrolysis, formamide does so by increasing the reaction rate between ImpA and 5'-phosphorylated DNA by ∼10-fold. The method described here enables straightforward preparation of chemically adenylated adapters with higher than 90% yield, simplifying reagent preparation for NGS.

Indexed as

DNAOrganophosphorus CompoundsHigh-Throughput Nucleotide SequencingOligonucleotidesRNADNAisopropyl methylphosphonic acidOligonucleotidesOrganophosphorus CompoundsRNAadenylationformamideimidazolideRNA ligation

Identifiers

PMID37059467
PMCPMC10275264

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.